Abstract
The combination of variable telomere length in cancer cells and shorter telomere length in cancerassociated stromal cells strongly correlates with progression to prostate cancer metastasis and cancer death. The implication is that telomere length measurements have potential not only as prognostic indicators of prostate cancer outcomes but also as risk stratification enrichment biomarkers for individualized therapeutic interventions.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1096-1098 |
| Number of pages | 3 |
| Journal | Cancer discovery |
| Volume | 3 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 2013 |
ASJC Scopus subject areas
- Oncology